Dr Reddy's launches Doxycycline Capsules in the US
Dr. Reddy's Laboratories announced its launch of Doxycycline Capsules, 40 mg in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy's Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content